Medicine and Dentistry
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
Chimeric Antigen Receptor
100%
Cancer Immunotherapy
100%
Neoplasm
36%
Immunocompetent Cell
18%
Immunotherapy
9%
Tumor Progression
9%
Metastatic Carcinoma
9%
Cancer
9%
Tumor Cell
9%
Targeted Therapy
9%
Vascular Bundle
9%
Carcinogenesis
9%
Natural Killer Cell
9%
T Cell
9%
Chimeric Antigen Receptor Natural Killer Cell
9%
Tumor Microenvironment
9%
Immunosurveillance
9%
Cell Signaling Pathway
9%
Tumor Angiogenesis
9%
Keyphrases
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Chimeric Antigen Receptor T Cells (CAR-T)
100%
Tumor Immunotherapy
100%
Immune Cells
18%
Natural Killer Cells
18%
Tumor
9%
Tumor Metastasis
9%
Signaling Pathway
9%
Tumor Cells
9%
Genetic Modification
9%
Overexpression
9%
Blood Vessels
9%
Breast
9%
Targeted Therapy
9%
T Cells
9%
Deregulation
9%
Poor Prognosis
9%
Tumor Microenvironment
9%
Tumor Cell Proliferation
9%
Antitumor
9%
Tumorigenesis
9%
Tumor Angiogenesis
9%
Gastroesophageal Cancer
9%
Tumor Immune Surveillance
9%
T Antigen
9%
Human Tumors
9%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Immunotherapy
100%
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
Chimeric Antigen Receptor
100%
Tumor Growth
9%
Carcinogenesis
9%
Tumor Microenvironment
9%